Dashboard
Poor long term growth as Operating profit has grown by an annual rate -24.13% of over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 903 Cr (Micro Cap)
151.00
40
1.07%
0.18
2.06%
3.10
Total Returns (Price + Dividend) 
Latest dividend: 7.5 per share ex-dividend date: Aug-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Fairchem Organics Technical Momentum Shifts Amid Mixed Market Signals
Fairchem Organics, a key player in the Specialty Chemicals sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition in price trends and technical indicators, underscoring a nuanced outlook for investors amid broader market dynamics.
Read More
Fairchem Organics: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals
Fairchem Organics, a player in the specialty chemicals sector, has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. Despite ongoing challenges in financial performance, recent technical signals and valuation metrics have prompted a nuanced reassessment of the company’s standing within its industry.
Read More
Fairchem Organic Sees Revision in Market Assessment Amid Challenging Financial Trends
Fairchem Organic, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling caution for investors amid persistent underperformance and subdued operational metrics.
Read More Announcements 
Corporate Actions 
No Upcoming Board Meetings
Fairchem Organics Ltd has declared 75% dividend, ex-date: 04 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 15 FIIs (6.18%)
Fih Mauritius Investments Limited (52.83%)
360 One Special Oppurtunities Fund - Series 7 (3.61%)
18.29%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -14.91% vs 8.51% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -34.19% vs 98.31% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -20.08% vs -2.78% in Sep 2024
Growth in half year ended Sep 2025 is -89.08% vs 8.84% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -9.30% vs -7.18% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -25.61% vs -9.17% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -13.45% vs -3.94% in Mar 2024
YoY Growth in year ended Mar 2025 is -45.75% vs -6.90% in Mar 2024






